Ocugen Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Ocugen Inc 's ROA in the second quarter of 2026?
Ocugen Inc recorded a cumulative net loss of $-82 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -114.72%.

However, within the Healthcare sector 764 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4369, from total ROA ranking in the first quarter of 2026 at 5026.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	137.41 %	-11.72 %	-47.75 %	-6.81 %	32.19 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-82	-72	-68	-74	-67
Return On Assets (TTM)	-114.72 %	-135.48 %	-123.83 %	-114.24 %	-101.65 %
OCGN's Total Ranking	# 4369	# 5026	# 4428	# 4461	# 4483
Total Assets (TTM) in million	127	57	44	58	54
Seq. Total Assets Change	123.6 %	30.77 %	-24.45 %	7.47 %	-16.86 %
Seq. Net Income Change	-	-	-	-	-

OCGN's 5 Years Annual ROA >> Back to OCGN Management Effectiveness >> Compare OCGN ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 118
Sector	# 765
Overall	# 4278

Return On Assets Statistics
High	Average	Low
-30.78 %	-94.18 %	-341.2 %
(Sep 30 2020)		(Sep 30 2019)

Financial Statements
Ocugen Inc 's Assets	$ 127 million	OCGN's Balance sheet
Ocugen Inc 's Income	$ -25 million	Quarterly OCGN's Income Statement
OCGN's Income by Division		See OCGN's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-47.22 %	27.72 %	-40.53 %	2.63 %	286.32 %
Total Assets in million	44	82	65	109	106
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-68	-54	-63	-81	-58
Annual Return On Assets	-155.91 %	-65.51 %	-97.72 %	-74.95 %	-55.19 %

OCGN's 5 Years Annual ROA >> Back to OCGN Management Effectiveness >> Compare OCGN ROA to its Competitors

More Return On Assets Ratios
OCGN's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
OCGN's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for OCGN's Competitors
Subscribers only: Roa for Ocugen Inc 's Suppliers
Subscribers only: Return On Assets for OCGN's Customers

You may also want to know
OCGN's Roi	OCGN's Inventory Turnover Ratio	OCGN's Growth Rates	OCGN's Dividend Comparisons
	OCGN's Profitability Ratios	OCGN's Asset Turnover Ratio	OCGN's Dividend Growth
OCGN's Roe	OCGN's Valuation Ratios	OCGN's Financial Strength Ratios	OCGN's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:08:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.